4:01 PM
 | 
Apr 17, 2017
 |  BC Extra  |  Company News

Management tracks

Cell therapy company Juno Therapeutics Inc. (NASDAQ:JUNO) named Sunil Agarwal president of R&D. He was CMO of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).

Non-profit organization The Cancer Research Institute (New...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >